This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

REGULATORY

MEXT Funding Research Project to Propose New Business Models and Financing Methods to Promote Drug Development

A research project to identify challenges in R&D has been initiated with funding from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).

The research project, led by ...
> Read full story
ORGANIZATION
JPMA to Start Educational Program for Biopharmaceutical Manufacturing Next Spring: Biopharmaceutical Chief (Sep.04)
BUSINESS
Transformation of ARB Market Spurred by AGs, Power Map Changing Fast as Brand-Name Drugs Falter (Sep.04)
REGULATORY
PAFSC Committee Recommends Approval for 2 Regenerative Medicine Products (Sep.04)
BUSINESS
MSD Paid 13 Billion Yen to Doctors, Medical Institutions in 2014 (Sep.03)
BUSINESS
Merck Serono Japan Wants to Be Leader in Oncology, Fertility: President (Sep.03)
> More Latest News

Photosmore

  
JPMA to Start Educational Program for Biopharmaceutical Manufacturing Next Spring: Biopharmaceutical Chief (Sep.04)Merck Serono Japan Wants to Be Leader in Oncology, Fertility: President (Sep.03)Towa to Improve Production Efficiencies and Facilities at Yamagata Plant in Response to Rising Generic Demand (Sep.03)
  
Ryukaikon’s New Proposal Hints at “Sanction in NHI Price” for Makers that Don’t Share Distribution Costs (Sep.02)Cost-Effective Assessment Must Not Delay Patient Access: PhRMA’s HTA Chief (Sep.01)ASCO Immunotherapy Roundup - 9: Researcher Says Predominance of Anti-PD-1 Antibodies Not Assured (Sep.01)

News Categories

REGULATORY
MEXT Funding Research Project to Propose New Business Models and Financing Methods to Promote Drug Development(Sep.04)
   PAFSC Committee Recommends Approval for 2 Regenerative Medicine Products(Sep.04)
   PMDA to Select Products for Sakigake Review; “Probably 5 to 10” Will Be Designated: Official(Sep.03)
BUSINESS
   Transformation of ARB Market Spurred by AGs, Power Map Changing Fast as Brand-Name Drugs Falter(Sep.04)
   MSD Paid 13 Billion Yen to Doctors, Medical Institutions in 2014(Sep.03)
Merck Serono Japan Wants to Be Leader in Oncology, Fertility: President(Sep.03)
ORGANIZATION
   JPMA to Start Educational Program for Biopharmaceutical Manufacturing Next Spring: Biopharmaceutical Chief(Sep.04)
   Ryukaikon’s New Proposal “Will Greatly Promote the Improvement of Distribution”: JPWA President(Sep.02)
Cost-Effective Assessment Must Not Delay Patient Access: PhRMA’s HTA Chief(Sep.01)
ACADEMIA
ASCO Immunotherapy Roundup - 9: Researcher Says Predominance of Anti-PD-1 Antibodies Not Assured(Sep.01)
   Japan’s National Database “World’s Largest in Scale”: Kyoto University Prof. Nakayama(Aug.20)
   Genome Sequencing Study of Biliary Tract Cancer Suggests Effectiveness of Immune Checkpoint Therapy: National Cancer Center(Aug.12)

Commentary

How Will Industry Counter Proposed Re-Pricing of “Huge Seller” Drugs?

Lexicon

Pricing premium for the promotion of new drug development and the elimination/resolution of off-label use:
新薬創出・適応外薬解消等促進加算(新薬創出加算)

The Column

No… Your Company Is Not like a Family!

Archives

PMDA to Select Products for Sakigake Review; “Probably 5 to 10” Will Be Designated: Official(Sep.03)
5 Companies Find 46 Unreported ADR Cases as a Result of Self-Inspections(Sep.03)
Towa to Improve Production Efficiencies and Facilities at Yamagata Plant in Response to Rising Generic Demand(Sep.03)
AZ, Daiichi Sankyo Team Up for Development, Commercialization of Nasal Flu Vaccine in Japan(Sep.03)
Ryukaikon’s New Proposal “Will Greatly Promote the Improvement of Distribution”: JPWA President(Sep.02)

Most Read

1.
MHLW Mulls Ordering Pfizer to Improve Bi...
2.
Pfizer Japan Slapped with Biz Improvemen...
3.
Takeda Slapped with Business Improvement...
4.
Chuikyo Rep Nakagawa Casts Doubt on 80% ...
5.
GSK Adjusts Shipments of Hepatitis B Tre...

News Calendar